AngioDynamics Enrolls First Patient in Clinical Research Office of Endourological Society NanoKnife Safety and Efficacy Study

AngioDynamics (NASDAQ: ANGO ) announced the enrollment of the first patient at Academic Medical Center, Amsterdam, The Netherlands, by the Clinical Research Office of the Endourological Society (CROES) in an investigator-led, multi-center study assessing the safety, efficacy and patient satisfaction of the NanoKnife System for the ablation of prostate